- Home
- ORMP vs KRMD Comparison
ORMP vs KRMD Comparison
Compare ORMP & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORMP | KRMD |
|---|---|---|
| Founded | 2002 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.3M | 192.5M |
| IPO Year | 2010 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ORMP | KRMD |
|---|---|---|
| Price | $4.29 | $4.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | ★ 500.7K | 161.3K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | ★ 412.50 | 53.85 |
| EPS | ★ 0.91 | N/A |
| Revenue | $2,000,000.00 | ★ $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | $4.73 | ★ N/A |
| Revenue Growth | ★ 49.25 | 22.23 |
| 52 Week Low | $1.98 | $2.91 |
| 52 Week High | $5.19 | $6.61 |
Technical Indicators
Market Signals| Indicator | ORMP | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 58.11 |
| Support Level | $3.69 | $3.84 |
| Resistance Level | $5.10 | $4.68 |
| Average True Range (ATR) | 0.34 | 0.21 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 37.19 | 69.40 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.